Patent foramen ovale in patients with cryptogenic stroke: evaluation and secondary prevention
10.3760/cma.j.issn.1673-4165.2022.10.010
- VernacularTitle:隐源性卒中患者的卵圆孔未闭：评价和二级预防
- Author:
Liping WANG
1
;
Xiujuan SONG
;
Dongyu CHI
;
Yanyan LIU
;
Linshan WAN
;
Tianxin SUN
;
Yige ZHANG
;
Han ZHANG
Author Information
1. 河北医科大学第二医院，河北省神经病学重点实验室，石家庄 050000
- Keywords:
Stroke;
Brain ischemia;
Foramen ovale, patent;
Echocardiography;
Ultrasonography, Doppler, transcranial;
Risk factors;
Secondary prevention
- From:
International Journal of Cerebrovascular Diseases
2022;30(10):777-781
- CountryChina
- Language:Chinese
-
Abstract:
Cryptogenic stroke (CS) is a type of stroke that can not find the exact cause after using the standard clinical examination procedure of stroke. In recent years, many studies have shown that patent foramen ovale (PFO) is closely associated with CS, and its main pathogenesis is paradoxical embolism. In clinical practice, ultrasound is often used for PFO screening. In the context of PFO, the secondary prevention of CS includes drug therapy and PFO closure, but the choice of treatment is still controversial. Screening and evaluation of possible PFO will help to develop secondary prevention strategies for patients with CS, especially those who can benefit from PFO closure.
